4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-055990
Chief Executive Officer sold 7,800 shares at an average $33.95 ($264,796)
From the SEC's structured data for this filing
Trades in this filing
Ciechanover Isaac E. · Chief Executive Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-10-22 | Sale : show line 1 in the form | −3,105 | $33.66 | $104,514 | 47,773 | I |
| 2018-10-22 | Sale : show line 2 in the form | −795 | $34.26 | $27,237 | 46,978 | I |
| 2018-10-23 | Sale : show line 3 in the form | −1,400 | $33.17 | $46,438 | 45,578 | I |
| 2018-10-23 | Sale : show line 4 in the form | −1,700 | $34.39 | $58,463 | 43,878 | I |
| 2018-10-23 | Sale : show line 5 in the form | −800 | $35.18 | $28,144 | 43,078 | I |
| Open-market sales · 7,800 sh · avg $33.95 · $264,796 | ||||||
Loading xslF345X03/doc4.xml…